Lion Tcr

Developer of T-cell therapeutics for the treatment of viral infections

placeSingapore, Singapore, Singapore calendar_todayFounded 2015 groups32 employees language liontcr.com

Registered entities

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 296 times.

YearFilings
20171
20181
20193
20201
20213
20221
20232
20241
20251

Investor mix

25 investors on record; lead investors include Westlake Ventures, ABC Capital.

Investor typeCountShare
Venture capital312%
Private equity28%
Other / undisclosed2080%
Coming soon